
Microgenics Corp.
Free shipping on orders over $99 · 30-day returns
CEDIA TACROLIMUS ASSAY is an FDA 510(k)-cleared medical device (K050206) manufactured by Microgenics Corp.. This device is classified under the Clinical Chemistry specialty. FDA Device Class II (Special Controls) — moderate risk, requires 510(k) clearance. FDA clearance granted on March 14, 2005. Regulation: 8.